スナップチャート
While healthcare private equity investors were busy around the world during 2018, the Asia-Pacific region saw the largest increase in activity. Deal volume there surged from 61 transactions in 2017 to 88 in 2018, while disclosed value more than doubled to $15.8 billion. Much of the increase came in the provider sector, as investors anticipate increased healthcare demand across China and India, where populations are aging and incomes rising. Still, the US remains the largest healthcare investing market, with 149 deals and $29.6 billion in announced value for 2018 in North America. Europe, meanwhile, saw a leveling off in activity, as deal count nudged up to 73. Disclosed value reached a record $17.8 billion, boosted by two large biopharma deals. The extent of cross-border growth in Europe is limited, however, because of reimbursement system and language constraints.
Nirad Jain and Kara Murphy are partners with Bain & Company and coleaders of the firm’s Healthcare Private Equity team.
Global Healthcare Private Equity and Corporate M&A Report
After a banner year in 2018, competition for fundamentally strong healthcare assets shows no signs of abating.